eISSN: 2450-5722
ISSN: 2450-5927
Journal of Health Inequalities
Current issue Archive Online first About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
vol. 4
Letter to the Editor

Influenza vaccination in Italy: current scenarioand critical issues

Chiara de Waure

Department of Experimental Medicine, University of Perugia, Italy
J Health Inequal 2018; 4 (2): 84-85
Online publish date: 2018/12/31
Article file
Get citation
PlumX metrics:
Influenza-like illnesses affect around 8-9% of the Italian population each year, but the cumulative incidence has shown important variations throughout time, from 4% to 15% [1, 2]. Incidence rates show the lowest values among the elderly and the highest among children [2]. Looking at data from the 1999/2000 season onwards, the peak of incidence rate was as low as 2.7 cases per 1000 persons and as high as 16 per 1000 persons. Elderly individuals (≥ 65 years old) and people with chronic medical conditions are at higher risk for influenza-related complications and deaths and are recommended vaccination by the World Health Organisation [3]. In line with that, the last Italian National Immunisation Plan (NIP) recommends influenza vaccination to all elderly individuals and to people at risk because of chronic diseases at any age. Pregnant women and healthcare workers are also recommended vaccination. The NIP also indicates 95% as the optimal goal of vaccination coverage and 75% as the minimum target [4].
Annual influenza vaccination in Italy is provided free-of-charge by the Local Health Authorities or by general practitioners. In particular, the latter may be considered the real “operations managers” of influenza vaccination because of their close contact with the potential targets [5].
Currently, three types of influenza vaccines are available in Italy: the trivalent inactivated and adjuvanted vaccines, which contain A(H1N1), A(H3N2), and a B strain (belonging to Victoria or Yamagata lineage) and the quadrivalent inactivated vaccines that contain both the B strain lineages beyond A(H1N1) and A(H3N2). The recommendations released by the Italian Ministry of Health (MoH) for the 2018/2019 season have for the first time encouraged preferential use of the adjuvanted trivalent vaccine in individuals ≥75 years of age and the quadrivalent inactivated vaccines in younger age groups [6]. Nevertheless, there is heterogeneity among Italian regions with respect to the procurement of single vaccine types because of fiscal federalism.
Following the NIP, the Italian MoH recommendations highlight the importance of achieving a minimum vaccination coverage of 75% and to aim for 95% [6]. Nonetheless, in Italy, the vaccination coverage did not ever reach the minimum goal. In fact, after an increasing trend up to the 2005/2006 season, vaccination coverage among elderly individuals started to decrease reaching values below 50% in the 2014/2015 and 2015/2016 seasons with important regional differences [7]. Data from the last season showed a national coverage of 52.7% among elderly individuals with a range from 35.3% to 63.4% across Italian regions. Evidence suggests that the reduction of vaccination coverage led to a significant increase in influenza-like illnesses [8]. Furthermore, in Italy, a +13% excess mortality linked to the peak in influenza was shown in the 2015 winter season in elderly individuals [9].
Actually, the 2018/2019 season seems to show a turnaround, with a growing percentage of people requiring to be vaccinated and a projected increase in vaccination coverage [10]. The increased demand could help improve vaccination coverage, although it remains important to also strengthen the commitment of public health authorities [11] and access to vaccination.


The author reports no conlict of interest.


1. Ministero della Salute. Prevenzione e controllo dell’influenza. [Ministry of Health. Influenza prevention and control]. Available from: http://www.salute.gov.it/portale/influenza/dettaglioContenutiInfluenza.jsp?lingua=italiano&id=685&area =influenza &menu=vuoto (accessed: 4 November 2018).
2. Epicentro. Influenza. Aspetti epidemiologici in Italia. [Epicenter. Influenza. Epidemiological aspects in Italy]. Available from: http://www.epicentro.iss.it/influenza/epidemiologia-italia (accessed: 4 November 2018).
3. WHO. WHO Influenza (Seasonal) Fact sheet. Available from: http://www.who.int/mediacentre/factsheets/fs211/en/ (accessed: 4 November 2018).
4. Piano Nazionale Prevenzione Vaccinale 2017-2019. [National Vaccination Prevention Plan 2017-2019]. Available from: http://www. salute.gov.it/imgs/C_17_pubblicazioni_ 2571_ allegato.pdf (accessed: 4 November 2018).
5. Desiante F, Caputi G, Cipriani R, et al. Assessment of coverage and analysis of the determinants of adherence to influenza vaccination in the general practitioners of Taranto. Ann Ig 2017; 29: 256-263.
6. Ministero della Salute. Prevenzione e controllo dell’influenza: raccomandazioni per la stagione 2018-2019. [Ministry of Health. Influenza prevention and control: recommendations for the 2018-2019 season]. Available from: http://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno= 2018&codLeg=64381&parte=1%20&serie=null (accessed: 4 No­vember 2018).
7. Vaccinazione antinfluenzale in Italia: coperture vaccinali negli anziani (età >= 65 anni) (per 100 abitanti). Stagioni 1999‐2000/2017‐2018. [Influenza vaccination in Italy: vaccination coverage in the elderly (age> = 65 years) (per 100 inhabitants). Seasons 1999-2000 / 2017-2018]. Available from: http://www.salute.gov.it/imgs/C_17_tavole_19_allegati_iitemAllegati_0_fileAllegati_itemFile_3_file.pdf (accessed: 4 November 2018).
8. Manzoli L, Gabutti G, Siliquini R, et al. Association between vaccination coverage decline and influenza incidence rise among Italian elderly. Eur J Public Health 2018; 28: 740-742.
9. Michelozzi P, De’ Donato F, Scortichini M, et al. On the increase in mortality in Italy in 2015: analysis of seasonal mortality in the 32 municipalities included in the Surveillance system of daily mortality. Epidemiol Prev 2016; 40: 22-28.
10. Influenza. Prevenzione in crescita? [Influenza. Is prevention increasing?]. Available from: https://www.edott.it/SanitaQuotidiana/DettaglioNews/?data=17-12-2018&id4Me = d1c8 6f64-9939-47f4-9635-470ade2a4b5b (accessed: 4 November 2018).
11. Levi M, Bonanni P, Biffino M, et al. Influenza vaccination 2014-2015: Results of a survey conducted among general practitioners in Italy. Hum Vaccin Immunother 2018; 14: 1342-1350.
This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Quick links
© 2023 Termedia Sp. z o.o.
Developed by Bentus.